Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR18034 for Postoperative Analgesia After Hemorrhoidectomy
CTR20230652Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Mar 2023
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of liposomal ropivacaine in hemorrhoid, postoperative pain, sponsored by Hengrui Therapeutics. Started Mar 2023; status: completed.
02
Drugs
liposomal ropivacaine
03
Conditions
hemorrhoidpostoperative pain
Beyond the preview
Go deeper on CTR20230652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230652.